Article

AAO testimony challenges 'passive verification'

Washington, DC-Testifying before the House Energy and Commerce Subcommittee on Commerce, Trade, and Consumer Protection, American Academy of Ophthalmology (AAO) member Oliver D. Schein, MD, MPH, MBA, called the practice of passive verification a flaw in the Fairness to Contact Lens Consumer Act (FCLCA).

Washington, DC-Testifying before the House Energy and Commerce Subcommittee on Commerce, Trade, and Consumer Protection, American Academy of Ophthalmology (AAO) member Oliver D. Schein, MD, MPH, MBA, called the practice of passive verification a flaw in the Fairness to Contact Lens Consumer Act (FCLCA).

"The academy believes [passive verification] lowers the bar for patient safety and opens the door for prescription verification failures that can ultimately result in patient harm," Dr. Schein said. He added that, in the interest of patient safety, contact lens prescriptions should be positively verified before being dispensed to the user.

Dr. Schein asserted that, since the FCLCA went into effect in August 2004, dispensers have logged numerous verification abuses that place contact lens sales ahead of patient safety, He cited a warning letter sent by the FTC in October 2005 to 1-800 Contacts Inc. resulting from frequent complaints about potential violations. Additionally, under the FCLCA, the FTC was required to study antitrust concerns in the sale of prescription contact lenses. The February 2005 study concluded: "It does not support the hypothesis that sellers are able to limit competition or harm consumers by charging higher prices for limited distribution or private label lenses."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
© 2025 MJH Life Sciences

All rights reserved.